✦ LIBER ✦

Suppressed thyroid-stimulating hormone secretion in patients treated with interleukin-2 and interferon-?2b for metastatic melanoma

✍ Scribed by M�nig, H. ;Hauschild, A. ;Lange, S. ;F�lsch, U. R.

Publisher: Springer-Verlag
Year: 1994
Tongue: English
Weight: 398 KB
Volume: 72
Category: Article
ISSN: 1432-1440
DOI: 10.1007/bf00577739

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Increased expression of perforin and gra

Increased expression of perforin and granzyme B genes in patients with metastatic melanoma treated with recombinant interleukin-2

✍ Marie-Bénédicte Leger-Ravet; Claire Mathiot; Alain Portier; Maud Brandely; Pierr 📂 Article 📅 1994 🏛 Springer-Verlag 🌐 English ⚖ 792 KB

Phase II trial of recombinant human inte

Phase II trial of recombinant human interleukin-2 and interferon-alpha-2a: Implications for the treatment of patients with metastatic melanoma

✍ Omar Eton; Moshe Talpaz; Kyoo H. Lee; Jeanne M. Rothberg; Joanna M. Brell; Rober 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 664 KB

Production of tumor necrosis factor α an

Production of tumor necrosis factor α and interferon γ in interleukin-2-treated melanoma patients: Correlation with clinical toxicity

✍ James S. Economou; Mary Hoban; Jeffrey D. Lee; Richard Essner; Stephen Swisher; 📂 Article 📅 1991 🏛 Springer-Verlag 🌐 English ⚖ 548 KB

Cytotoxic In vitro function in patients

Cytotoxic In vitro function in patients with metastatic renal cell carcinoma before and after alpha-2b-interferon therapy effects of activation with recombinant interleukin-2

✍ Cristina Feruglio; Renato Zambello; Livio Trentin; Pietro Bulian; Tiziano France 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 658 KB

Randomized trial of treatment with cispl

Randomized trial of treatment with cisplatin and interleukin-2 either alone or in combination with interferon-α-2a in patients with metastatic melanoma : A Federation Nationale des Centres de Lutte Contre le Cancer Multicenter, parallel study

✍ Thierry Dorval; Sylvie Négrier; Christine Chevreau; Marie-Françoise Avril; Danie 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB 👁 2 views

## Background: The objective of the current study was to evaluate the response rate, survival, and toxicity of treatment with cisplatin and high dose intravenous continuous infusion interleukin-2 (il-2) with or without interferon-alpha-2a (ifn) in patients with metastatic melanoma. ## Methods: On